GdpP截短介导金黄色葡萄球菌临床分离株的β-内酰胺耐药
研究对来自奥地利的10株与英国的11株mec基因阴性、高水平β-内酰胺耐药的金黄色葡萄球菌(含人源与牛源)进行耐药表型检测与全基因组测序。结果在7株奥地利分离株和11株英国分离株中检出环二腺苷酸磷酸二酯酶GdpP截短,互补完整gdpP可恢复对青霉素类的敏感性并消除生长缺陷,提示GdpP失活与β-内酰胺耐药相关。
要点
- mec基因阴性菌株亦可表现高水平β-内酰胺耐药,需警惕单基因检测的局限。
- GdpP截短在耐药人源与牛源分离株中反复出现,互补实验支持其因果作用。
- 耐药株还携带PBP、AcrB、YjbH及pbp4启动子突变,可能共同参与耐药。
核心结论
- GdpP的天然失活可见于人源与动物源金黄色葡萄球菌,并与β-内酰胺耐药及生长受损相关,提示仅凭单基因存在与否推断药敏可能存在局限。
研究设计与样本
- 对奥地利10株人源与英国11株牛源mec基因阴性MRSA分离株,采用纸片扩散法、Etest和VITEK 2进行耐药表型检测,并行全基因组测序,另对4株代表性分离株做gdpP互补实验。
主要发现
- 在耐药分离株中检出PBP、AcrB、YjbH及pbp4启动子突变(含新突变),而近缘敏感株中未见。
- GdpP截短见于10株奥地利分离株中的7株和11株英国分离株中的10株。
- 4株代表性分离株互补完整gdpP后恢复对青霉素类的敏感性,并消除截短所致生长缺陷。
临床怎么用
- 对mec基因阴性但表型耐β-内酰胺的金黄色葡萄球菌,不应仅凭单基因检测判定敏感,应结合表型药敏。
局限性
- 原文未系统报告样本来源细节与耐药水平的具体数值,互补实验仅覆盖4株代表性分离株。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: High-level β-lactam resistance in MRSA is mediated in the majority of strains by a mecA or mecC gene. In this study, we identified 10 mec gene-negative MRSA human isolates from Austria and 11 bovine isolates from the UK showing high levels of β-lactam resistance and sought to understand the molecular basis of the resistance observed. METHODS: Different antimicrobial resistance testing methods (disc diffusion, Etest and VITEK® 2) were used to establish the β-lactam resistance profiles for the isolates and the isolates were further investigated by WGS. RESULTS: A number of mutations (including novel ones) in PBPs, AcrB, YjbH and the pbp4 promoter were identified in the resistant isolates, but not in closely related susceptible isolates. Importantly, a truncation in the cyclic diadenosine monophosphate phosphodiesterase enzyme, GdpP, was identified in 7 of the 10 Austrian isolates and 10 of the 11 UK isolates. Complementation of four representative isolates with an intact copy of the gdpP gene restored susceptibility to penicillins and abolished the growth defects caused by the truncation. CONCLUSIONS: This study reports naturally occurring inactivation of GdpP protein in Staphylococcus aureus of both human origin and animal origin, and demonstrates clinical relevance to a previously reported association between this truncation and increased β-lactam resistance and impaired bacterial growth in laboratory-generated mutants. It also highlights possible limitations of genomic determination of antibiotic susceptibility based on single gene presence or absence when choosing the appropriate antimicrobial treatment for patients.
引用
- Ba X, Kalmar L, Hadjirin NF, et al. Truncation of GdpP mediates β-lactam resistance in clinical isolates of Staphylococcus aureus. J Antimicrob Chemother. 2019. PMID: 30759229. doi:10.1093/jac/dkz013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。